Search results
Results from the WOW.Com Content Network
The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...
Cisplatin is a chemical compound with formula cis-[Pt(NH 3) 2 Cl 2]. It is a coordination complex of platinum that is used as a chemotherapy medication used to treat a number of cancers . [ 3 ] These include testicular cancer , ovarian cancer , cervical cancer , bladder cancer , head and neck cancer , esophageal cancer , lung cancer ...
Overall survival at two years was 82.2 per cent in the durvalumab group and 75.2 per cent in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer but ...
Gemcitabine, sold under the brand name Gemzar, among others, [1] is a chemotherapy medication used to treat cancers. [3] It is used to treat testicular cancer , [ 4 ] breast cancer , ovarian cancer , non-small cell lung cancer , pancreatic cancer , and bladder cancer .
Cisplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Germ cell tumours (including testicular cancer), ovarian cancer, cervical cancer, small cell and non-small cell lung cancer, mesothelioma, squamous cell head and neck cancer, oesophageal cancer, gastric cancer, bladder cancer and osteosarcoma
Durvalumab [1] AstraZeneca UK: unresectable Stage III non-small cell lung cancer: Ibalizumab [1] Theratechnologies: human immunodeficiency virus type 1 (HIV-1) infection Brentuximab vedotin [1] Seattle Genetics: Hodgkin lymphoma: Ipilimumab [1] Bristol-Myers Squibb: renal cell carcinoma: Nivolumab [1] Bristol-Myers Squibb: renal cell carcinoma ...
1. Bop-It. Bop-It has a lot of things going on for the listener that are pretty close to insufferable. For starters, every sound effect this game makes is cartoonish and insane.
Durvalumab (Imfinzi) is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules. Durvalumab is approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma who: